---
title: "Immix Biopharma (IMMX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IMMX.US/norm.md"
symbol: "IMMX.US"
name: "Immix Biopharma"
parent: "https://longbridge.com/en/quote/IMMX.US.md"
datetime: "2026-03-10T19:50:45.333Z"
locales:
  - [en](https://longbridge.com/en/quote/IMMX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMMX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMMX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/IMMX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IMMX.US/norm.md)


# Immix Biopharma (IMMX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2376 | -0.2209 | -0.1529 | -0.1628 | -0.2430 |
| ROE | -469.77% | -371.88% | -159.07% | -124.98% | -138.01% |
| Revenue | - | - | - | - | - |
| Net income | -7.59M | -6.62M | -4.54M | -4.81M | -7.15M |
| Operating income | -7.66M | -6.72M | -4.68M | -4.99M | -7.39M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 20.08M | 15.64M | 19.89M | 22.95M | 25.14M |
| Leverage | 2.43 | 3.36 | 2.07 | 1.73 | 1.43 |
| BVPS | 0.2502 | 0.1638 | 0.3444 | 0.4812 | 0.6387 |
| Turnover | - | - | - | - | - |
| Cash & STI | 15.95M | 11.64M | 15.92M | 17.68M | 19.69M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 3.36M | 3.18M | 3.09M | 2.73M | 2.37M |
| Net debt | -14.84M | -10.60M | -14.86M | -16.61M | -18.60M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -5.91M | -5.31M | -1.69M | -1.48M | -4.04M |
| Investing CF | -372456.00 | -127630.00 | -67713.00 | -507151.00 | -271542.00 |
| Financing CF | 10.61M | 1.11M | - | 0.0000 | 0.0000 |
| Free CF | -3.80M | -2.91M | 208380.00 | -207804.00 | -1.48M |
| OCF coverage | -1585.63% | -4160.29% | -2488.65% | -291.08% | -1486.36% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -372456.00 | -127630.00 | -67713.00 | -507151.00 | -271542.00 |